ATHA - Dinamika pendapatan YoY sajrone rolas wulan kepungkur Athira Pharma Corp

The Athira Pharma, Inc. (ATHA) R&D pipeline is undergoing a revision stage following ambiguous tests, with the business's success tied to the efficacy of phosgonimetone in treating Alzheimer's. This trailing twelve-month revenue chart on GURU.Markets illustrates sales dynamics, where the 0.00 metric confirms the current level. US-based development centers and an innovative small-molecule platform ensure the company's stability.
athira.com (ATHA) - rincian metrik lan laporan keuangan

Investors utilize revenue dynamics to assess operational resilience and business scalability. For Athira Pharma, Inc. (ATHA), which is currently undergoing restructuring following setbacks in Alzheimer's therapy, this metric is critical. The year-over-year revenue volatility for the TTM captures the daily change in annual turnover, reflecting the actual growth rate. A negative trend here signals a risk of capital freeze. Current stagnation confirms the urgent need for asset portfolio diversification.